Insider Trading activities of Xoma Corp insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Xoma Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Xoma Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Xoma Corp since 2005. The reporting company's ticker symbol is XOMA. The reporting company's CIK number is 791908.
The total value of stock buying since 2005 is $14,191,517.
The total value of stock sales since 2005 is $54,944,674.
The total value of stock option exercises since 2005 is $1,057,740.


 1   2 

Table 2. Detailed insider stock purchases, sales, and option exercises of Xoma Corp insiders (XOMA) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-05-28 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 1,785 4.22 7,532
2014-05-28 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 4,667 .00 0
2014-05-28 Wyszomierski Jack L (Director) Option Ex 5,600 .00 0
2014-05-15 Varian John (CEO) Sale 10,000 3.55 35,520
2014-05-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2014-05-13 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 10,000 3.84 38,400
2014-04-15 Varian John (CEO) Sale 10,000 4.07 40,650
2014-04-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2014-03-18 Neal James R (VP Business Development) Sale 2,671 6.32 16,870
2014-03-18 Klein Thomas (Chief Commercial Officer) Sale 30,965 6.32 195,574
2014-03-18 Klein Thomas (Chief Commercial Officer) Option Ex 80,667 .00 0
2014-03-18 Varian John (CEO) Sale 21,329 6.32 134,713
2014-03-18 Varian John (CEO) Option Ex 36,907 .00 0
2014-03-18 Kurland Fred (CFO & VP Finance) Sale 5,915 6.32 37,359
2014-03-18 Kurland Fred (CFO & VP Finance) Option Ex 10,875 .00 0
2014-03-18 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 3,419 6.32 21,594
2014-03-18 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 9,500 .00 0
2014-03-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 17,649 6.31 111,418
2014-03-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 36,347 1.01 36,819
2014-03-17 Varian John (CEO) Sale 10,000 6.03 60,290
2014-03-17 Varian John (CEO) Option Ex 10,000 1.24 12,400
2014-03-10 Limber Joseph M (Director) Option Ex 5,600 .00 0
2014-02-18 Varian John (CEO) Sale 10,000 7.55 75,480
2014-02-18 Varian John (CEO) Option Ex 10,000 1.24 12,400
2014-02-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 6,000 7.54 45,270
2014-02-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 6,000 3.04 18,240
2014-01-21 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 6,000 8.27 49,608
2014-01-21 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 5,694 3.04 17,309
2014-01-15 Varian John (CEO) Sale 10,000 8.28 82,790
2014-01-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2014-01-09 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 20,000 8.00 160,040
2014-01-09 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 20,000 1.69 33,800
2013-12-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 6,000 5.67 33,990
2013-12-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 6,000 3.04 18,240
2013-12-16 Varian John (CEO) Sale 10,000 5.44 54,370
2013-12-16 Varian John (CEO) Option Ex 10,000 1.24 12,400
2013-12-02 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 20,000 6.00 120,000
2013-12-02 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 20,000 1.69 33,800
2013-11-27 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 4,696 4.54 21,319
2013-11-27 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 4,696 3.04 14,275
2013-11-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 1,304 4.08 5,317
2013-11-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 1,304 2.36 3,077
2013-11-15 Varian John (CEO) Sale 10,000 4.13 41,330
2013-11-15 Varian John (CEO) Option Ex 10,000 1.24 12,400
2013-11-13 Varian John (CEO) Sale 111,146 3.90 433,732
2013-11-13 Varian John (CEO) Option Ex 100,665 .00 0
2013-11-13 Walbert Timothy P (Director) Option Ex 4,498 .00 0
2013-11-13 Kurland Fred (CFO & VP Finance) Sale 12,331 3.91 48,238
2013-11-13 Kurland Fred (CFO & VP Finance) Option Ex 22,596 .00 0
2013-11-13 Bowes William K Jr (Director) Option Ex 4,498 .00 0
2013-11-13 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 8,346 3.91 32,657
2013-11-13 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 22,652 .00 0
2013-11-13 Van Ness W Denman (Director) Option Ex 6,876 .00 0
2013-11-13 Wyszomierski Jack L (Director) Option Ex 4,498 .00 0
2013-10-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 746 4.71 3,510
2013-10-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 746 2.36 1,760
2013-10-15 Varian John (Director and CEO) Sale 10,000 4.59 45,950
2013-10-15 Varian John (Director and CEO) Option Ex 10,000 1.24 12,400
2013-09-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 6,000 4.53 27,185
2013-09-16 Varian John (Director and CEO) Sale 10,000 4.59 45,860
2013-09-16 Varian John (Director and CEO) Option Ex 10,000 1.24 12,400
2013-08-19 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 6,000 3.74 22,416
2013-08-15 Varian John (Director and CEO) Sale 10,000 3.92 39,210
2013-08-15 Varian John (Director and CEO) Option Ex 10,000 1.24 12,400
2013-08-14 Varian John (Director and CEO) Sale 51,647 3.86 199,409
2013-08-14 Varian John (Director and CEO) Option Ex 94,574 .00 0
2013-08-14 Kurland Fred (CFO & VP Finance) Sale 7,498 3.86 28,949
2013-08-14 Kurland Fred (CFO & VP Finance) Option Ex 19,064 .00 0
2013-08-14 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 6,002 3.86 23,173
2013-08-14 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 16,265 .00 0
2013-08-14 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 10,520 3.86 40,617
2013-08-14 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 26,748 .00 0
2013-07-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 6,000 4.71 28,230
2013-07-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 6,000 2.70 16,200
2013-07-15 Varian John (Director and CEO) Sale 10,000 4.81 48,070
2013-07-15 Varian John (Director and CEO) Option Ex 10,000 1.24 12,400
2013-06-28 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 567 3.45 1,955
2013-06-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 6,000 .00 0
2013-06-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 3,130 2.36 7,386
2013-06-17 Varian John (Director and CEO) Sale 10,000 .00 0
2013-06-17 Varian John (Director and CEO) Option Ex 10,000 1.24 12,400
2013-06-11 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 10,000 .00 0
2013-06-11 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 10,000 1.69 16,900
2013-05-29 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 1,797 4.16 7,475
2013-05-28 Walbert Timothy P (Director) Option Ex 2,800 .00 0
2013-05-28 Bowes William K Jr (Director) Option Ex 2,800 .00 0
2013-05-28 Van Ness W Denman (Director) Option Ex 3,150 .00 0
2013-05-28 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 4,667 .00 0
2013-05-28 Wyszomierski Jack L (Director) Option Ex 2,800 2.69 7,532
2013-05-20 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 6,000 2.08 12,480
2013-05-20 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 785 2.36 1,852
2013-05-15 Varian John (Director and CEO) Sale 10,000 .00 0
2013-05-15 Varian John (Director and CEO) Option Ex 10,000 1.24 12,400
2013-05-14 Scannon Patrick J Md Phd (Exec. VP & CSO) Sale 10,000 .00 0
2013-05-14 Scannon Patrick J Md Phd (Exec. VP & CSO) Option Ex 10,000 1.69 16,900
2013-04-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 6,000 .00 0
2013-03-28 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 1,498 3.32 4,967
2013-03-19 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Sale 6,990 3.29 22,997
2013-03-18 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 18,205 .00 0
2012-12-31 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 833 2.28 1,899
2012-11-14 Varian John (Director and CEO) Sale 40,587 2.56 103,821
2012-11-14 Kurland Fred (CFO & VP Finance) Sale 9,111 2.56 23,305
2012-11-14 Scannon Patrick J Md Phd (Executive Vice President) Sale 8,773 2.56 22,441
2012-11-13 Varian John (Director and CEO) Option Ex 100,666 .00 0
2012-11-13 Walbert Timothy P (Director) Option Ex 4,499 .00 0
2012-11-13 Kurland Fred (CFO & VP Finance) Option Ex 22,596 .00 0
2012-11-13 Bowes William K Jr (Director) Option Ex 4,499 .00 0
2012-11-13 Scannon Patrick J Md Phd (Executive Vice President) Option Ex 22,653 .00 0
2012-11-13 Van Ness W Denman (Director) Option Ex 6,876 .00 0
2012-11-13 Wyszomierski Jack L (Director) Option Ex 4,499 .00 0
2012-10-29 Baker Felix (Director) Buy 4,722,666 3.00 14,167,998
2012-09-28 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 542 3.51 1,900
2012-06-29 Rubin Paul D (Sr. VP Clinical Dev. & CMO) Option Ex 661 2.83 1,871
2012-03-30 Rubin Paul D (VP Clinical Dev. & CMO) Option Ex 1,229 2.63 3,234
2011-11-11 Van Ness W Denman (Director) Sale 698 1.60 1,116
2011-09-30 Rubin Paul D (VP Clinical Dev. & CMO) Option Ex 1,022 1.66 1,699
2011-03-25 Kurland Fred (CFO & VP Finance) Buy 5,000 3.26 16,319
2005-08-17 Boyle J David Ii (VP, Finance, and CFO) Buy 5,000 1.44 7,200
2005-05-11 Dellio Clarence L (Sr VP, Operations an) Sale 10,974 1.41 15,473
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of XOMA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Xoma Corp (symbol XOMA, CIK number 791908) see the Securities and Exchange Commission (SEC) website.